Morning Movers Archives - Page 71 of 3071

CENTURY LITHIUM COMMENDS FIRST PHOSPHATE IN MAKING LFP BATTERY CELLS USING CENTURY LITHIUM MATERIAL

July 8, 2025

VANCOUVER, BC, July 8, 2025 /PRNewswire/ - Century Lithium Corp. (TSXV: LCE) (OTCQX: CYDVF) (Frankfurt: C1Z) ("Century Lithium" or "the Company")...

Citius Pharmaceuticals Regains Compliance with Nasdaq Minimum Bid Price Requirement

July 8, 2025

CRANFORD, N.J. , July 8, 2025 /PRNewswire/ -- Citius Pharmaceuticals, Inc. ("Citius Pharma" or the "Company") (Nasdaq: CTXR) today announced...

Rallybio Sells Interest in REV102 Program to Recursion Pharmaceuticals

July 8, 2025

NEW HAVEN, Conn.--(BUSINESS WIRE)--Rallybio Corporation (Nasdaq: RLYB), a clinical-stage biotechnology company translating scientific advances into transformative therapies for patients with...

Plus Therapeutics Announces Initial Patients Successfully Treated in ReSPECT-LM Dose Optimization Trial for REYOBIQ™ in Leptomeningeal Metastases

July 8, 2025

HOUSTON, July 08, 2025 (GLOBE NEWSWIRE) -- Plus Therapeutics, Inc. (Nasdaq: PSTV) (the “Company”), a clinical-stage pharmaceutical company developing targeted...

BTC Digital Ltd. Announces Major Milestone on Georgia 20 MW Mining Project and Introduces Advanced Liquid-Cooling Technology for the First Time

July 8, 2025

SINGAPORE, July 8, 2025 /PRNewswire/ -- BTC Digital Ltd. ("BTCT" or the "Company") (NASDAQ: BTCT), a leading blockchain technology company, today...

Oncolytics Biotech® Highlights Transformative Pelareorep Survival Data in Multiple Tumors and Commitment to Registration-Enabling Studies

July 8, 2025

Comparison with multiple landmark first-line metastatic pancreatic ductal adenocarcinoma studies substantiates strong two-year survival benefit of 21.9% vs. 9.2% historical...

ZyVersa Therapeutics Supports FDA-Authorized Emergency Compassionate Use of Cholesterol Efflux Mediator™ VAR 200 in a Patient with ApoCII Amyloidosis

July 8, 2025

ApoCII amyloidosis, resulting from abnormal organ deposition of toxic fibrillar amyloid proteins, is an ultra-rare condition that mostly affects the...

i-80 Gold Provides Progress Update on its New Development Plan

July 8, 2025

RENO, Nev., July 8, 2025 /PRNewswire/ - i-80 GOLD CORP. (TSX: IAU) (NYSE American: IAUX) ("i-80" or the "Company") is pleased...

Harmonic Sets DOCSIS 4.0 Record with 14 Gbps Downstream Speed at CableLabs Interoperability Event

July 8, 2025

SAN JOSE, Calif., July 8, 2025 /PRNewswire/ -- Harmonic (NASDAQ: HLIT) today announced a record-breaking demonstration at the recent CableLabs®...

Garmin smartwatches add turn-by-turn directions with Google Maps

July 8, 2025

Google Maps app arrives to the Connect IQ Store, providing directions on the wristOLATHE, Kan., July 8, 2025 /PRNewswire/ --...

Evogene Announces Completion of Transaction for the Sale of Lavie Bio’s Activity to ICL

July 8, 2025

REHOVOT, Israel, July 8, 2025 /PRNewswire/ -- Evogene Ltd. (NASDAQ: EVGN) (TASE: EVGN), a leading computational biology company utilizing cutting-edge artificial...

SolarBank’s 7.2 MW Hoadley Hill Project Successfully Completes Major Interconnection Study on Path to Permit

July 8, 2025

Project to Power Equivalent of 850 Homes TORONTO, July 8, 2025 /PRNewswire/ - SolarBank Corporation (NASDAQ: SUUN) (Cboe CA: SUNN) (FSE:...

Soligenix Corporate Update Letter – Key Highlights and Upcoming Milestones

July 8, 2025

PRINCETON, N.J., July 8, 2025 /PRNewswire/ -- Soligenix, Inc. (Nasdaq: SNGX) (Soligenix or the Company), a late-stage biopharmaceutical company focused...

Cryoport’s MVE Biological Solutions Introduces Next Generation Vapor Shippers

July 8, 2025

New SC vapor shipper series improves reliability through extended hold times and patented impact-absorbing and Vapor Shield Technology NASHVILLE, Tenn.,...

CARGO Therapeutics Enters into Agreement to Be Acquired by Concentra Biosciences for $4.379 in Cash per Share Plus a Contingent Value Right

July 8, 2025

SAN CARLOS, Calif., July 08, 2025 (GLOBE NEWSWIRE) -- CARGO Therapeutics, Inc. (“CARGO” or the “Company”) (NASDAQ: CRGX), a biotechnology...

ProKidney Reports Statistically and Clinically Significant Topline Results for the Phase 2 REGEN-007 Trial Evaluating Rilparencel in Patients with Chronic Kidney Disease and Diabetes

July 8, 2025

Full results from REGEN-007 are being held and will be submitted to the American Society of Nephrology 2025 Kidney Week...

Avant Technologies and Partner, Ainnova, Launch Transformative Preventative Care Model for Chronic Patients Across Latin America

July 8, 2025

LAS VEGAS, July 8, 2025 /PRNewswire/ -- Avant Technologies, Inc. (OTCQB: AVAI) ("Avant" or the "Company"), and its JV partner,...

NUTEX HEALTH HOSPITALS’ 2025 Q2 AWARDS

July 8, 2025

HOUSTON, July 8, 2025 /PRNewswire/ -- Nutex Health Inc. ("Nutex Health" or the "Company") (NASDAQ: NUTX), a physician-led, integrated healthcare...

Garmin launches the Force Current kayak trolling motor with unrivaled maneuverability

July 8, 2025

Industry's first hands-free kayak propulsion system allows anglers to focus on fishingOLATHE, Kan., July 8, 2025 /PRNewswire/ -- Garmin (NYSE:...

CalciMedica to Participate in the H.C. Wainwright 4th Annual Kidney Virtual Conference

July 8, 2025

LA JOLLA, Calif., July 8, 2025 /PRNewswire/ -- CalciMedica Inc. ("CalciMedica" or the "Company") (Nasdaq: CALC), a clinical-stage biopharmaceutical company...

The Alkaline Water Company Executes Memorandum of Understanding for Strategic Expansion Into Wholesale Distribution and Manufacturing

July 8, 2025

GLENDALE, Ariz., July 8, 2025 /PRNewswire/ -- The Alkaline Water Company, Inc. (OTC: WTER -- hereinafter referred to as the...

Borr Drilling Limited- Notice of Special General Meeting

July 8, 2025

HAMILTON, Bermuda, July 8, 2025 /PRNewswire/ -- Borr Drilling Limited (the "Company") (NYSE "BORR") advises that the Company will convene...

BOXABL Launches Search for New Directors and Executive Leadership

July 7, 2025

LAS VEGAS, July 7, 2025 /PRNewswire/ -- As BOXABL prepares for its next stage of growth and expansion, the company is...

KalVista Pharmaceuticals Announces FDA Approval of EKTERLY® (sebetralstat), First and Only Oral On-demand Treatment for Hereditary Angioedema

July 7, 2025

CAMBRIDGE, Mass. & SALISBURY, England--(BUSINESS WIRE)--KalVista Pharmaceuticals, Inc. (Nasdaq: KALV) today announced that the U.S. Food and Drug Administration (FDA)...

Carnival Corporation & plc Announces Upsizing and Pricing of $3.0 Billion 5.75% Senior Unsecured Notes Offering

July 7, 2025

Proceeds from the upsized offering of senior unsecured notes to be used to fully repay borrowings under the senior secured...

Blue Owl Capital Launches U.S. Diversified Direct Lending Strategy with Australia’s Koda Capital

July 7, 2025

Blue Owl Credit Income Fund AUT (OCIC-A) now available to Australian financial advisors and their clients in partnership with Australia's...

Thumzup Media Corporation Announces Closing of $6.5 Million Registered Direct Offering of Series C Preferred Stock at $60.00 Per Share (The Functional Equivalent of $6.00 Per Share of Common Stock)

July 7, 2025

LOS ANGELES, July 7, 2025 /PRNewswire/ -- Thumzup Media Corporation ("Thumzup" or the "Company") (Nasdaq: TZUP), a digital asset accumulator and...

FS Credit Opportunities Corp. (FSCO) Declares Distribution for July 2025

July 7, 2025

PHILADELPHIA, July 7, 2025 /PRNewswire/ -- The Board of Directors of FS Credit Opportunities Corp. (the Fund) (NYSE: FSCO) announced...

FibroBiologics’ to Present at Exclusive Live Investor Webinar and Q&A Session on July 10

July 7, 2025

HOUSTON, July 07, 2025 (GLOBE NEWSWIRE) -- FibroBiologics, Inc. (Nasdaq: FBLG) (“FibroBiologics”), a clinical-stage biotechnology company with 275+ patents issued...

Natera Presents Data at ESMO GI on its Tissue-Free Latitude™ MRD* Assay, Demonstrating Excellent Overall Performance in Colorectal Cancer

July 7, 2025

AUSTIN, Texas--(BUSINESS WIRE)--Natera, Inc. (NASDAQ: NTRA), a global leader in cell-free DNA and precision medicine, today announced data from a...

Enovix Declares Shareholder Warrant Dividend

July 7, 2025

FREMONT, Calif., July 07, 2025 (GLOBE NEWSWIRE) -- Enovix Corporation (Nasdaq: ENVX) (“Company” or “Enovix”), a global high-performance battery company,...

Global Industrial Enzyme Markets: Innovation, Impact, and Growth

July 7, 2025

"The global industrial enzyme market is experiencing rapid growth, driven by advances in biotechnology and increasing demand across sectors like...

Worksport Delivers Record Production With 100%+ Margin Growth as Revenue Tracks Toward $20M Milestone Ahead of Clean-Tech Product Launch

July 7, 2025

West Seneca, New York, July 07, 2025 (GLOBE NEWSWIRE) -- Worksport Ltd. (NASDAQ: WKSP) (“Worksport” or the “Company”), a U.S....

Enovix Launches AI-1™: A Revolutionary Silicon-Anode Smartphone Battery Platform

July 7, 2025

FREMONT, Calif., July 07, 2025 (GLOBE NEWSWIRE) -- Enovix Corporation (Nasdaq: ENVX) (“Enovix”), a leader in advanced silicon battery technology,...

Enovix Announces Preliminary Second Quarter 2025 Financial Results

July 7, 2025

FREMONT, Calif., July 07, 2025 (GLOBE NEWSWIRE) -- Enovix Corporation (Nasdaq: ENVX) (“Company” or “Enovix”), a global high-performance battery company,...

Artelo Biosciences Announces Positive Preclinical Efficacy with ART12.11 in Stress-Induced Depression Model

July 7, 2025

ART12.11, the Patented CBD:TMP Cocrystal, Demonstrates Potent Antidepressant-Like Activity and Cognitive Benefits Over Leading SSRI Data Being Presented at the 35th...